共 106 条
[1]
Jemal A(2005)Cancer statistics, 2005 CA Cancer J Clin 55 10-30
[2]
Murray T(2004)FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions Eur J Nucl Med Mol Imaging 31 S70-S79
[3]
Ward E(2001)Clinical role of positron emission tomography in oncology Lancet Oncol 2 157-164
[4]
Scheidhauer K(2002)Whole-body FDG-PET imaging in the management of patients with cancer Semin Nucl Med 32 35-46
[5]
Walter C(2004)Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer AJR Am J Roentgenol 183 479-486
[6]
Seemann MD(2002)Comparison of fluorodeoxyglucose positron emission tomography and “conventional diagnostic procedures” for the detection of distant metastases in breast cancer patients Nucl Med Commun 23 857-864
[7]
Bomanji JB(2003)F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging Invest Radiol 38 250-256
[8]
Costa DC(2002)Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer Ann Surg 236 619-624
[9]
Ell PJ(2004)Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) Am J Clin Oncol 27 407-410
[10]
Hustinx R(2001)Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management J Natl Cancer Inst 93 630-635